Rallybio (RLYB) Earnings Date & Reports

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

RLYB is expected to report earnings to fall 213.32% to -28 cents per share on May 13

Q1'25

Est.

$-0.28

Q4'24

Beat

by $0.55

Q3'24

Beat

by $0.09

Q2'24

Missed

by $0.30

Q1'24

Est.

$-0.47

The last earnings report on March 13 showed earnings per share of 25 cents, beating the estimate of -30 cents. With 149.19K shares outstanding, the current market capitalization sits at 12.38M.

View a ticker or compare two or three

Compare

RLYB